Exporter, Buying House
Pacific Pharmaceuticals Ltd.
Claim Your Company
Bangladesh,Dhaka
Average Lead Time: 34 days
Annual Revenue: US$2.5 Million - US$5 Million
Membership Year: 1988
Plant Area:
Below 1,000 square meters
Accepted Payment Modes:
USD, JPY, GBP
Certification:
BRC, BRC
Main Products:
Antidiabetic, Antiulcerant & Pain Killer
Company ProfilePacific Pharmaceuticals LtdBangladeshCompany overviewPacific Pharma is one of the leading and fastest growing pharmaceutical companies in Bangladesh, involved in the service to the nation and mankind by manufacturing and marketing ethical finished pharmaceuticals having belief in super quality.Right from the inception, quality is the passion of Pacific Pharma. In the backdrop of increasingly intensive demand of quality products, Pacific Pharma today is well equipped with state-of-the-art technological facilities with ISO 9001:2000 & 140001:2004 certification complying cGMP having innovative spirit to build an image as a superior quality drug manufacturer.Product and MarketingPresently, 83 (Eighty three) generics in different strengths and dosage forms of various therapeutic classes are being manufactured & marketed by us. The company is having the highest range of oral anti-diabetic drugs and has been attaining the leadership position in oral antidiabetic sector for about one decade maintaining super quality. Some other products of the company now hold coveted positions with the major market shares in their respective therapeutic groups. Besides existing brands we are in continuous process of introducing more and more generics.Production and In-house CapabilitiesPacific Pharma has been enriched with vast assortment of modern and sophisticated process equipments and machineries for designing, optimizing and qualifying manufacturing processes within designed parameters, specifications and requirements. The arrangement for operations relating to the manufacture, processing and packaging of products including the requisite utility facilities have been kept segregated and independent from each area section-wise having individual air-lock system.Pacific Pharma has the facilities for the annual production of 630 million tablets having 3 individual tablet sections, 72 million capsules in hard gelatin shell, 40 million soft gelatin capsules, 14 million bottles of liquid products in sophisticated fully automatic in-line machinery, 4 million bottles of powder for suspension and pelletization production of 50 metric tons.Human ResourcesSince marketing is the core of a company and teamwork is the secret of marketing success, Pacific Pharma believes in and practises accordingly. The company represents a unique mix of experienced professionals with solid background in marketing & sales of medicines.More than 700 employees are enrolled in the company who are working in the factory (A devoted loyal workforce totaling around 150 people mans the factory, out of whom 55 qualified professionals are working in the Production, Quality Assurance and Product Development Departments), different sales centers, head office and in the field (over 350 highly professional marketing personnel of Pacific Pharma are representing the company).Social ResponsibilitiesPacific Pharma is not a mere business concern; it works with a missionary zeal to serve the ailing humanity too. The company is actively engaged in social welfare activities and routinely patronizes and donates to various charitable, voluntary and blood donating organizations as part of our philanthropic activities. Pacific Pharma also extends its donation to the government & private relief funds during natural disasters and in organizing free medical camps.Vision and AspirationsTo keep the tragic memory of Shuvo unfading and with a view to serve the ailing children Pacific Pharma has been marketing all the life saving child drugs at break-even price since its inception.Pacific Pharma is now driven by its vision not only to be the ICON in the countrys pharma sector through ethical and pragmatic approach of marketing but also aspires to become one of the key players in the untapped pharmaceutical markets in Afro-Asian and neighbouring countries.